Friday, October 23, 2026

USD/CNH Is 2% Down In The Last 21 Sessions

ViaNews Editorial Team

December 7, 2023

USD/CNH Is 2% Down In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 2.02% for the last 21 sessions. At 04:06 EST on Thursday, 7 December, USD/CNH (USDCNH) is $7.17.

USD/CNH's yearly highs and lows, it's 0.003% up from its 52-week low and 0.022% down from its 52-week high.

News about

  • Japanese yen remains on the defensive against usd; 100-day SMA caps usd/jpy. According to FXStreet on Tuesday, 5 December, "The USD/JPY pair might then accelerate the fall towards the next relevant support near the 145.45-145.40 region en route to the 145.00 psychological mark and the 50% Fibo. ", "From a technical perspective, the USD/JPY pair on Monday found some support and attracted buyers near the 146.20 region, representing the 38.2% Fibonacci retracement level of the July-October rally. "
  • Usd/jpy analysis: the future of the downward correction - 05 December 2023. According to DailyForex on Tuesday, 5 December, "Before that, the USD/JPY underwent strong selling operations that pushed it toward the 146.22 support level, its lowest in nearly three months. ", "According to the performance on the daily time frame chart, the price of the USD/JPY is still on a downward correction path. "
  • Usd/jpy trades better bid above 147.00 after dovish boj commentary. According to FXStreet on Wednesday, 6 December, "Further, a minor rebound in the US Treasury bond yields is helping the USD/JPY to stay afloat amid a retreat in the US Dollar across the board. ", "The swift US Dollar rebound lifted USD/JPY from daily lows of 146.56, as the pair went on to settle Tuesday almost unchanged at 147.20. "
  • Usd/jpy forecast: continues to hang about support against yen - 06 December 2023. According to DailyForex on Wednesday, 6 December, "It's essential to understand that the USD/JPY currency pair is significantly influenced by U.S. interest rates, especially the 10-year yield. ", "Analyzing USD/JPY Trends Amid SpeculationIn contrast, a downward movement breaking below Monday's hammer pattern signals a possible drop to the ¥145 level. "
  • Usd/jpy: near-term resistance approached and speculative - 06 December 2023. According to DailyForex on Wednesday, 6 December, "Speculators who are placing quick hitting trades and pursuing technical directions likely understand the ups and downs of the USD/JPY quite well and are not immune to placing buying positions on the currency pair even if they continue to think the mid-term outlook is bearish.USD/JPY and the Potential to Change Direction Again", "The USD/JPY appears to be in a rather intriguing value range via its current price realm. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Crunch: Late-Stage Readouts and Regulatory Milestones Converge on the Ivonescimab PDUFA Date
October 2026 is dense with clinical and regulatory news. Phase 3 trials hit primary endpoints (ALOFT-IPF, RESTORE-3), long-term data came out (MIUDELLA at 6 years, QUILT-3.032), and the FDA accepted Roche's vamikibart BLA. Scholar Rock resubmitted its apitegromab MAA to the EMA. The next catalysts are ESMO 2026 (Oct 23) and the Nov 14 FDA PDUFA date for ivonescimab, followed by Maritime-1 primary completion in January 2027. The speculative QAIAx items (QIII pilot, microcities patent) are a weak, tangential thread with little financial substance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,426 source documents archived
Query this data → isubstrate.com